Evidence map›Paper›PMID 31687651›Full record

ArticleJBMR plus2019

Bisphosphonate Use and Fractures in Adults with Hypophosphatasia.

Kate Rassie, Michael Dray, Toshimi Michigami, Tim Cundy

Open access · goldAbstract read
In one paragraph

Article in JBMR plus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Low alkaline phosphatase in adults: implications for the diagnosis of hypophosphatasia during evaluation for osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  2. The Challenge of Hypophosphatasia Diagnosis in Patients with Fibromyalgia.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Observational
  10. Review
  11. Review
  12. Review
  13. Hypophosphatasia: from birth to adulthood.Archives of endocrinology and metabolism · 2023
    Review
  14. Review
  15. Atypical Femoral Fracture in Hypophosphatasia: A Systematic Review.International journal of endocrinology · 2023
    Article
  16. Article
  17. Identifying adult hypophosphatasia in the rheumatology unit.Orphanet journal of rare diseases · 2022
    Article
  18. Anabolic actions of parathyroid hormone in a hypophosphatasia mouse model.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Kate RassieDepartment of Endocrinology Greenlane Clinical Centre Auckland New Zealand.ORCID https://orcid.org/0000-0003-1492-483X
Michael DrayDepartment of Pathology Waikato Hospital Hamilton New Zealand.
Toshimi MichigamiDepartment of Bone & Mineral Research Osaka Women's & Children's Hospital Isumi Japan.
Tim CundyDepartment of Endocrinology Greenlane Clinical Centre Auckland New Zealand.
Greenlane Clinical Centre · NZOsaka Women's and Children's Hospital · JPUniversity of Auckland · NZWaikato Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adults with hypophosphatasia (HPP) may suffer femoral fractures resembling the atypical femoral fractures that can occur with long-term bisphosphonate treatment, and there is an emerging consensus that bisphosphonates should not be used in adults with HPP and low bone mass. However, the spectrum of HPP in adults is wide: ranging from the severely affected-who commonly have osteomalacia-through to the minimally affected. The former typically have biallelic and the latter, heterozygous

Indexed as

ALPLATYPICAL FEMORAL FRACTURESGENE MUTATIONSHYPOPHOSPHATASIAOSTEOMALACIAOSTEOPOROSIS

Identifiers

PMID31687651
PMCPMC6820463
OpenAlexW2965810166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.